Structure

InChI Key QCHFTSOMWOSFHM-WPRPVWTQSA-N
Smile CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
InChI
InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C11H16N2O2
Molecular Weight 208.26
AlogP 1.16
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 3.0
Polar Surface Area 44.12
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 15.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Muscarinic acetylcholine receptor M1 agonist PubMed
Primary Target
M3 receptor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Glaucoma, Angle-Closure 4 D015812 ClinicalTrials
Glaucoma 4 D005901 ClinicalTrials
Xerostomia 4 D014987 ClinicalTrials
Ocular Hypertension 4 D009798 ClinicalTrials
Presbyopia 3 D011305 ClinicalTrials
Urinary Incontinence 1 D014549 ClinicalTrials

Related Entries

Scaffolds

Salt

Side Effects from Label

Side effects Relative Frequency (%) Labels
General disorders and administration site conditions Hyperhidrosis 68.0
General disorders and administration site conditions Hyperhidrosis 40.0
General disorders and administration site conditions Hyperhidrosis 29.0
Nervous system disorders Headache
General disorders and administration site conditions Chills 15.0
Gastrointestinal disorders Nausea 15.0
Infections and infestations Rhinitis 14.0
General disorders and administration site conditions Flushing 13.0
Nervous system disorders Headache 13.0
General disorders and administration site conditions Asthenia 12.0
Cardiac disorders Dizziness 12.0
Renal and urinary disorders Pollakiuria 12.0
Nervous system disorders Headache 11.0
Renal and urinary disorders Pollakiuria 10.0
General disorders and administration site conditions Flushing 9.0
General disorders and administration site conditions Hyperhidrosis
Infections and infestations Influenza
Infections and infestations Influenza 9.0
Gastrointestinal disorders Nausea
Gastrointestinal disorders Nausea 9.0
Renal and urinary disorders Pollakiuria 9.0
General disorders and administration site conditions Flushing 8.0
Nervous system disorders Headache
Eye disorders Lacrimation increased
Gastrointestinal disorders Pharyngitis
Infections and infestations Rhinitis
Gastrointestinal disorders Diarrhoea
Gastrointestinal disorders Diarrhoea 7.0
Cardiac disorders Dizziness
Gastrointestinal disorders Dyspepsia
Gastrointestinal disorders Dyspepsia 7.0
General disorders and administration site conditions Hyperhidrosis
Renal and urinary disorders Pollakiuria
Infections and infestations Rhinitis
Infections and infestations Rhinitis 7.0
General disorders and administration site conditions Asthenia 6.0
Gastrointestinal disorders Diarrhoea 6.0
Cardiac disorders Dizziness 6.0
Infections and infestations Infection
Eye disorders Lacrimation increased 6.0
Gastrointestinal disorders Nausea 6.0
Gastrointestinal disorders Diarrhoea
Cardiac disorders Dizziness 5.0
Gastrointestinal disorders Dyspepsia
General disorders and administration site conditions Oedema 5.0
Gastrointestinal disorders Pharyngitis
Infections and infestations Rhinitis 5.0
Infections and infestations Sinusitis
Gastrointestinal disorders Abdominal pain
Gastrointestinal disorders Abdominal pain 4.0
Eye disorders Amblyopia 4.0
General disorders and administration site conditions Chills 4.0
Gastrointestinal disorders Diarrhoea 4.0
Cardiac disorders Dizziness
Gastrointestinal disorders Gastrointestinal pain
Gastrointestinal disorders Gastrointestinal pain 4.0
Gastrointestinal disorders Nausea
General disorders and administration site conditions Oedema
General disorders and administration site conditions Pain 4.0
Renal and urinary disorders Pollakiuria
Infections and infestations Sinusitis 4.0
Gastrointestinal disorders Vomiting 4.0
Gastrointestinal disorders Abdominal pain 3.0
General disorders and administration site conditions Asthenia
General disorders and administration site conditions Chills 3.0
Skin and subcutaneous tissue disorders Dermatitis
General disorders and administration site conditions Flushing
Gastrointestinal disorders Gastrointestinal pain 3.0
Vascular disorders Hypertension 3.0
Gastrointestinal disorders Pharyngitis 3.0
Skin and subcutaneous tissue disorders Rash
Gastrointestinal disorders Salivary hypersecretion 3.0
Gastrointestinal disorders Vomiting 3.0
Eye disorders Amblyopia
General disorders and administration site conditions Asthenia
General disorders and administration site conditions Asthenia 2.0
General disorders and administration site conditions Chills
Skin and subcutaneous tissue disorders Dermatitis 2.0
General disorders and administration site conditions Flushing
Infections and infestations Infection 2.0
General disorders and administration site conditions Pain
Gastrointestinal disorders Pharyngitis 2.0
Skin and subcutaneous tissue disorders Rash 2.0
General disorders and administration site conditions Chills
Vascular disorders Hypertension
Gastrointestinal disorders Vomiting

Cross References

Resources Reference
CAS NUMBER 92-13-7
ChEBI 8207
ChEMBL CHEMBL550
DrugBank DB01085
DrugCentral 2166
EPA CompTox DTXSID1021162
FDA SRS 01MI4Q9DI3
Human Metabolome Database HMDB0015217
Guide to Pharmacology 305
KEGG C07474
PDB 9PL
PharmGKB PA450962
PubChem 5910
SureChEMBL SCHEMBL15146
ZINC ZINC000000075008